{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:01:02Z","timestamp":1774947662047,"version":"3.50.1"},"reference-count":60,"publisher":"Consilium Medicum","issue":"5","license":[{"start":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T00:00:00Z","timestamp":1591315200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Aim. To assess the influence of anxiety and depressive disorders on joint destruction in patients with rheumatoid arthritis (RA).\r\nMaterials and methods. 128 RA-patients were included, 87% were women with a mean age of 47.411.3 years and a median of RA duration  96 [48; 228] months. At the inclusion most patients had moderate (n=56, 43.7%) and severe (n=48, 37.5%) disease activity according to DAS28. Joint destruction was classified as maximal in patients with radiographic stage III, IV and\/or osteonecrosis) and minimal in patients with stage I, II and no osteonecrosis. Pain intensity was measured with the BPI (Brief Pain Inventory) scale, severity of fatigue  with fatigue severity scale (FSS), clinically important fatigue was diagnosed in patients with FSS4. Anxiety and depressive disorders (ADD) were diagnosed by a licensed psychiatrist in 123 (96.1%) of RA-patients in accordance with ICD-10 in semi-structured interview. Severity of depression and anxiety was evaluated with Montgomery-Asberg Depression Rating Scale (MADRS) and Hamilton Anxiety Rating Scale (HAM-A). RA-patients with ADD were divided into the following treatment groups: 1  \u0441DMARDs (n=39), 2  \u0441DMARDs+PPT (sertraline or mianserine), n=43, 3  \u0441DMARDs+bDMARDs (n=32), 4  \u0441DMARDs+bDMARDs+PPT (sertraline or mianserine), n=9. Biologics treatment duration varied from 1 to 6 years, antidepressants  from 6 to 96 weeks. 83 (67.5%) RA patients were assessed at five-years follow-up. Linear regression analysis was conducted to determine factors associated with maximal join destruction.\r\nResults. According to linear regression analysis, maximal joint destruction at 5 years follow-up was associated with higher baseline BPImax, longer RA and ADD duration, clinically important fatigue at baseline, baseline extraarticular RA manifestations, recurrent depressive disorder at 5-years follow-up and treatment with cDMARDs only.\r\nConclusion. Recurrent depressive disorder without antidepressant treatment is an important predictor of progression of joint destruction in patients with rheumatoid arthritis.<\/jats:p>","DOI":"10.26442\/00403660.2020.05.000624","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T14:05:35Z","timestamp":1593439535000},"page":"22-32","source":"Crossref","is-referenced-by-count":10,"title":["Depression and severity of articular destruction in patients with rheumatoid arthritis"],"prefix":"10.26442","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1504-5645","authenticated-orcid":false,"given":"A. A.","family":"Abramkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9437-406X","authenticated-orcid":false,"given":"T. A.","family":"Lisitsyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5210-2605","authenticated-orcid":false,"given":"D. Yu.","family":"Veltishchev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5839-4637","authenticated-orcid":false,"given":"O. F.","family":"Seravina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. B.","family":"Kovalevskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4285-0869","authenticated-orcid":false,"given":"S. I.","family":"Glukhova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1598-8360","authenticated-orcid":false,"given":"E. L.","family":"Nasonov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2020,6,5]]},"reference":[{"key":"ref1","unstructured":"\u041d\u0430\u0441\u043e\u043d\u043e\u0432 \u0415.\u041b. \u0420\u0435\u0432\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. \u0420\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u0438\u0435 \u043a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0440\u0435\u043a\u043e\u043c\u0435\u043d\u0434\u0430\u0446\u0438\u0438. \u041c.: \u0413\u042d\u041e\u0422\u0410\u0420-\u041c\u0435\u0434\u0438\u0430, 2017 [Nasonov EL. Revmatologiya. Rossijskie klinicheskie rekomendacii. Moscow: GEOTAR-Media, 2017 (In Russ.)]."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2015-000064"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.153"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.14412\/2074-2711-2014-4-60-71"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210715"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Dougados M, Soubrier M, Antunez A, et al. Prevalence of comorbidities in rheumatoid arthritis (ra) and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis. 2013;72:600.","DOI":"10.1136\/annrheumdis-2013-eular.1787"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2015-512-521"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1080\/09638237.2016.1244719"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2055102916678107"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000489"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2013-634"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2012-1274"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/03009740500343260"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0000000000000462"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/art.39627"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-017-0649-5"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151212"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22515"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev306"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep170"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211284"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2016-339-345"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1011-1"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2016.02.052"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2015.06.001"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2013.01.002"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-3990-9"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2016.09.007"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1343-4"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.2217\/IJR.10.24"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/NDT.S114542"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X12438080"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1186\/1744-859X-10-9"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Hulejov\u00e1 H, Andr\u00e9s Cerezo L, Kuklov\u00e1 M, et al. Novel adipokine fibroblast growth factor 21 is increased in rheumatoid arthritis. Physiol Res. 2012;61(5):489-94. doi: 932324 [pii]","DOI":"10.33549\/physiolres.932324"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.55.5507"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Gururajan A, Clarke G, Dinan TG, Cryan JF. Molecular biomarkers of depression. Neurosci Biobehav Rev. 2016;64:101-33. doi: 10.1016\/ j.neubiorev.2016.02.011","DOI":"10.1016\/j.neubiorev.2016.02.011"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2009-141"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2018-173-183"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2018-439-448"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1002\/art.27584"},{"key":"ref41","unstructured":"\u0410\u043c\u0438\u0440\u0434\u0436\u0430\u043d\u043e\u0432\u0430 \u0412.\u041d., \u041a\u043e\u0439\u043b\u0443\u0431\u0430\u0435\u0432\u0430 \u0413.\u041d., \u0413\u043e\u0440\u044f\u0447\u0435\u0432 \u0414.\u0412. \u0438 \u0434\u0440. \u0412\u0430\u043b\u0438\u0434\u0430\u0446\u0438\u044f \u0440\u0443\u0441\u0441\u043a\u043e-\u044f\u0437\u044b\u0447\u043d\u043e\u0439 \u0432\u0435\u0440\u0441\u0438\u0438 Health Assessment Questionnaire (HAQ). \u041d\u0430\u0443\u0447\u043d\u043e-\u043f\u0440\u0430\u043a\u0442\u0438\u0447. \u0440\u0435\u0432\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f. 2004;(2):59-64 [Amirdjanova VN, Koilubaeva GM, Goryachev DV, et al. Validation of Russian version of Health Assessment Questionnaire (HAQ) Rheumatology Science and Practice. 2004;(2):59-64 (In Russ.)]."},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2009.10.001"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Van Gestel AM, Prevoo ML, van\u2019t Hof MA, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39(1):34-40.","DOI":"10.1002\/art.1780390105"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361-70.","DOI":"10.1111\/j.1600-0447.1983.tb09716.x"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5.","DOI":"10.1111\/j.2044-8341.1959.tb00467.x"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-9.","DOI":"10.1192\/bjp.134.4.382"},{"key":"ref47","unstructured":"\u041b\u0443\u0440\u0438\u044f \u0410.\u0420. \u0412\u044b\u0441\u0448\u0438\u0435 \u043a\u043e\u0440\u043a\u043e\u0432\u044b\u0435 \u0444\u0443\u043d\u043a\u0446\u0438\u0438 \u0447\u0435\u043b\u043e\u0432\u0435\u043a\u0430 \u0438 \u0438\u0445 \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u044f \u043f\u0440\u0438 \u043b\u043e\u043a\u0430\u043b\u044c\u043d\u044b\u0445 \u043f\u043e\u0440\u0430\u0436\u0435\u043d\u0438\u044f\u0445 \u043c\u043e\u0437\u0433\u0430. 2-\u0435 \u0438\u0437\u0434. \u041c.: \u0418\u0437\u0434-\u0432\u043e \u041c\u0413\u0423, 1962 [Lu-\u00ac rija AR. Vysshie korkovye funkcii cheloveka i ih narushenija pri lokal\u2019nyh porazhenijah mozga. 2nd ed. Moscow: Izd-vo MGU, 1962 (In Russ.)]."},{"key":"ref48","unstructured":"\u0425\u0435\u0440\u0441\u043e\u043d\u0441\u043a\u0438\u0439 \u0411.\u0413. \u041c\u0435\u0442\u043e\u0434 \u043f\u0438\u043a\u0442\u043e\u0433\u0440\u0430\u043c\u043c \u0432 \u043f\u0441\u0438\u0445\u043e\u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0435 \u043f\u0441\u0438\u0445\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u0439. \u041a.: \u0417\u0434\u043e\u0440\u043e\u0432\u044c\u044f. 1988 [Hersonskij BG. Metod piktogramm v psihodiagnostike psihicheskih zabolevanij. Kiev: Zdorov\u2019ja. 1988 (In Russ.).]"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6505(2000)9:5<201::AID-EVAN2>3.3.CO;2-P"},{"key":"ref50","unstructured":"\u0417\u0435\u0439\u0433\u0430\u0440\u043d\u0438\u043a \u0411.\u0412. \u041f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f \u043c\u044b\u0448\u043b\u0435\u043d\u0438\u044f. 2-\u0435 \u0438\u0437\u0434. \u041c.: \u0418\u0437\u0434-\u0432\u043e \u041c\u0413\u0423, 1962 [Zejgarnik BV. Patologija Myshlenija. 2nd ed. Moscow: Izd-vo MGU, 1962 (In Russ.)]."},{"key":"ref51","unstructured":"\u0410\u043b\u044c\u043c\u0430\u043d\u0430\u0445 \u043f\u0441\u0438\u0445\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0442\u0435\u0441\u0442\u043e\u0432. 3-\u0435 \u0438\u0437\u0434. \u041c.: \u041a\u0421\u041f, 1995 [Al\u2019manah psihologicheskih testov. 3rd ed. Moscow: KSP, 1995 (In Russ.)]."},{"key":"ref52","unstructured":"\u0420\u0443\u0431\u0438\u043d\u0448\u0442\u0435\u0439\u043d \u0421.\u042f. \u042d\u043a\u0441\u043f\u0435\u0440\u0438\u043c\u0435\u043d\u0442\u0430\u043b\u044c\u043d\u044b\u0435 \u043c\u0435\u0442\u043e\u0434\u0438\u043a\u0438 \u043f\u0430\u0442\u043e\u043f\u0441\u0438\u0445\u043e\u043b\u043e\u0433\u0438\u0438 \u0438 \u043e\u043f\u044b\u0442 \u043f\u0440\u0438\u043c\u0435\u043d\u0435\u043d\u0438\u044f \u0438\u0445 \u0432 \u043a\u043b\u0438\u043d\u0438\u043a\u0435. \u041f\u043e\u0434 \u0440\u0435\u0434. \u0413. \u0411\u0443\u0442\u0435\u043d\u043a\u043e. \u041c.: \u0418\u0437\u0434-\u0432\u043e \u0418\u043d\u0441\u0442\u0438\u0442\u0443\u0442\u0430 \u043f\u0441\u0438\u0445\u043e\u0442\u0435\u0440\u0430\u043f\u0438\u0438, 2010 [Rubinshtejn S.Ja. Jeksperimental\u2019nye metodiki patopsihologii i opyt primenenija ih v klinike. Butenko G, ed. Moscow: Izd-vo Instituta psihoterapii, 2010 (In Russ.)]."},{"key":"ref53","unstructured":"American Psychiatric Association, American Psychiatric Association. Task Force on DSM-IV. Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR. American Psychiatric Association, 2000."},{"key":"ref54","unstructured":"\u0413\u0435\u0440\u0430\u0441\u0438\u043c\u043e\u0432 \u0410.\u041d. \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0430\u044f \u0441\u0442\u0430\u0442\u0438\u0441\u0442\u0438\u043a\u0430. \u0423\u0447\u0435\u0431\u043d\u043e\u0435 \u043f\u043e\u0441\u043e\u0431\u0438\u0435. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u043e\u0435 \u0438\u043d\u0444\u043e\u0440\u043c\u0430\u0446\u0438\u043e\u043d\u043d\u043e\u0435 \u0430\u0433\u0435\u043d\u0442\u0441\u0442\u0432\u043e, 2007 [Gerasimov AN. Medicinskaja Statistika: Uchebnoe Posobie. Moscow: Medicinskoe informacionnoe agentstvo, 2007 (In Russ.)]."},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.14412\/1995-4484-2017-393-402"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165196"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1017\/S2045796017000579"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-017-1548-7"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22924"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/art.24428"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/34582\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/34582\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:42:19Z","timestamp":1634157739000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/34582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":60,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,6,5]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2020.05.000624","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}